Bulletin

WHO - Recommendations announced for influenza vaccine composition for the 2022-2023 northern hemisphere influenza season – 24 February 2022

LSW

The World Health Organization (WHO) today announced the recommendations for the viral composition of influenza vaccines for the 2022-2023 influenza season in the northern hemisphere. The announcement was made at an information session at the end of a 4-day Information Meeting on the Composition of Influenza Virus Vaccines, a meeting that is held twice annually.

The WHO organizes these consultations with an advisory group of experts gathered from WHO Collaboration Centres and WHO Essential Regulatory Laboratories to analyse influenza virus surveillance data generated by the WHO Global Influenza Surveillance and Response System. The recommendations issued are used by the national vaccine regulatory agencies and pharmaceutical companies to develop, produce, and license influenza vaccines for the following influenza season.

The periodic update of viruses contained in influenza vaccines is necessary for the vaccines to be effective due to the constant evolving nature of influenza viruses, including those circulating and infecting humans.

The WHO recommends that quadrivalent vaccines for use in the 2022-2023 influenza season in the northern hemisphere contain the following:

Egg-based vaccines

an A/Victoria/2570/2019 (H1N1)pdm09-like virus;

an A/Darwin/9/2021 (H3N2)-like virus;

a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and

a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

Cell culture- or recombinant-based vaccines

an A/Wisconsin/588/2019 (H1N1)pdm09-like virus;

an A/Darwin/6/2021 (H3N2)-like virus;

a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and

a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

The WHO recommends that trivalent vaccines for use in the 2022-2023 influenza season in the northern hemisphere contain the following:

Egg-based vaccines

an A/Victoria/2570/2019 (H1N1)pdm09-like virus;

an A/Darwin/9/2021 (H3N2)-like virus; and

a B/Austria/1359417/2021 (B/Victoria lineage)-like virus.

Cell culture- or recombinant-based vaccines

an A/Wisconsin/588/2019 (H1N1)pdm09-like virus;

an A/Darwin/6/2021 (H3N2)-like virus; and

a B/Austria/1359417/2021 (B/Victoria lineage)-like virus

About WHO

The World Health Organization provides global leadership in public health within the United Nations system. Founded in 1948, WHO works with 194 Member States, across six regions and from more than 150 offices, to promote health, keep the world safe and serve the vulnerable. Our goal for 2019-2023 is to ensure that a billion more people have universal health coverage, to protect a billion more people from health emergencies, and provide a further billion people with better health and wellbeing.

© 2018 LSW. All rights reserved | Styled by Zobia

Visitors No 157009